Skip to search formSkip to main contentSkip to account menu

resiquimod

Known as: 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol 
An imidazoquinolinamine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effect through… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Imidazoles

Narrower (2)

R 848S 28463

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.
2016
2016
IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod)
Different models of experimental allergic asthma have shown that the TLR7/8 agonist resiquimod (R848) is a potential inhibitor of… 
2016
2016
Intestinal tuft cell function
tumor models. Exercise triggers the release of epinephrine, which enhances the mobilization and tumor infiltration of NK cells… 
2013
2013
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.
2013
2013
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.
2010
2010
Topical resiquimod: a promising adjuvant for vaccine development?
Evaluation of: Chang BA, Cross JL, Najar HM, Dutz JP. Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine… 
2009
2009
Modulation of the allergic asthma transcriptome following resiquimod treatment.
Resiquimod is a compound belonging to the imidazoquinoline family of compounds known to signal through Toll-like receptor 7… 
Review
2009
Review
2009
Pharmacotherapy of actinic keratosis
Actinic keratosis (AK) represents the initial intraepidermal manifestation of abnormal keratinocyte proliferation with the… 
Highly Cited
2009
Highly Cited
2009
Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1
Plasmacytoid dendritic cells (pDCs) are responsible for the production of type I IFN during viral infection. Viral elimination by… 
Review
2003
Review
2003
Resiquimod 3M.
3M Pharmaceuticals is developing a topical formulation of resiquimod as an immunomodulator for the potential treatment of herpes… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)